NDC 69918-300

Lysteda

Tranexamic Acid

Lysteda is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Amring Pharmaceuticals Inc.. The primary component is Tranexamic Acid.

• Product ID: 69918-300_25ba7e46-0431-4948-8543-052c26bdabe8
• NDC: 69918-300
• Product Type: Human Prescription Drug
• Proprietary Name: Lysteda
• Generic Name: Tranexamic Acid
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2010-05-17
• Marketing Category: NDA / NDA
• Application Number: NDA022430
• Labeler Name: Amring Pharmaceuticals Inc.
• Substance Name: TRANEXAMIC ACID
• Active Ingredient Strength: 650 mg/1
• Pharm Classes: Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 69918-300-30

30 TABLET in 1 BOTTLE (69918-300-30)

• Marketing Start Date: 2010-05-17
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Lysteda" or generic name "Tranexamic Acid"

NDC	Brand Name	Generic Name
55566-2110	Lysteda	Lysteda
69918-300	Lysteda	Lysteda
0013-1114	Cyklokapron	tranexamic acid
0517-0960	Tranexamic Acid	tranexamic acid
0591-3720	Tranexamic Acid	Tranexamic Acid
14789-500	Tranexamic acid	TRANEXAMIC ACID
17478-017	Tranexamic Acid	Tranexamic Acid
17478-018	Tranexamic Acid	Tranexamic Acid
17478-217	TRANEXAMIC ACID	Tranexamic Acid
23155-166	Tranexamic Acid	Tranexamic Acid
23155-524	Tranexamic Acid	Tranexamic Acid
39822-1000	Tranexamic Acid	Tranexamic Acid
39822-1001	Tranexamic Acid	Tranexamic Acid